Captrust Financial Advisors Athersys, Inc Transaction History

Captrust Financial Advisors

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 23, 2022	SELL	$0.18 - $0.86 $6,172 - $29,491	-34,292 Reduced 89.55%	4,000 $1,000
Q2 2022 Aug 16, 2022	BUY	$0.18 - $0.86 $6,082 - $29,061	33,792 Added 750.93%	38,292 $10,000
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.4 $425 - $700	500 Added 12.5%	4,500 $4,000
Q3 2021 Nov 16, 2021	BUY	$1.33 - $1.77 $2,660 - $3,540	2,000 Added 100.0%	4,000 $5,000
Q2 2021 Aug 16, 2021	SELL	$1.41 - $1.94 $49,350 - $67,900	-35,000 Reduced 94.59%	2,000 $3,000
Q1 2021 May 17, 2021	SELL	$1.61 - $2.77 $14,960 - $25,738	-9,292 Reduced 20.07%	37,000 $67,000
Q4 2020 Feb 16, 2021	BUY	$1.55 - $2.24 $452 - $654	292 Added 0.63%	46,292 $81,000
Q3 2020 Nov 17, 2020	SELL	$1.91 - $3.08 $8,595 - $13,860	-4,500 Reduced 8.91%	46,000 $89,000
Q2 2020 Aug 14, 2020	BUY	$1.97 - $3.98 $4,925 - $9,950	2,500 Added 5.21%	50,500 $137,000
Q1 2020 May 15, 2020	BUY	$1.17 - $3.0 $7,020 - $18,000	6,000 Added 14.29%	48,000 $191,000
Q4 2019 Feb 14, 2020	BUY	$1.16 - $1.42 $3,479 - $4,260	3,000 Added 7.69%	42,000 $52,000
Q3 2019 Nov 14, 2019	BUY	$1.21 - $1.65 $35,090 - $47,850	29,000 Added 290.0%	39,000 $52,000
Q3 2018 Nov 15, 2018	BUY	$1.86 - $2.18 $18,600 - $21,800	10,000 New	10,000 $21,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.